feedback welcome

Vortioxetine-fluvoxamine

From Psychiatrynet

(Difference between revisions)
Jump to:navigation, search
[checked revision][draft revision]
Line 3: Line 3:
| to = fluvoxamine
| to = fluvoxamine
| stop =  
| stop =  
-
* '''Day 1:''' reduce dosage of vortioxetine to 5 mg/day.
+
{{stopVortioxetine}}
-
* '''Day 8:''' stop administration of vortioxetine.
+
| start =  
| start =  
* '''Day 8:''' start administration of fluvoxamine in a dosage of 50 mg/day.
* '''Day 8:''' start administration of fluvoxamine in a dosage of 50 mg/day.
{{Day22NoBloodlevelvortioxetine}}
{{Day22NoBloodlevelvortioxetine}}
| info =  
| info =  
-
* Occurrence of serotonin syndrome is theoretically possible, so caution is necessary.
+
* {{theorSS}}
* fluvoxamine is a inhibitor of CYP2C9, which metabolizes vortioxetine.}}
* fluvoxamine is a inhibitor of CYP2C9, which metabolizes vortioxetine.}}

Revision as of 12:49, 4 November 2015

Vortioxetine
Type Antidepressant
Group SMS
links
Medscape Vortioxetine
PubChem 9966051
PubMed Vortioxetine
Kompas (Dutch) Vortioxetine
Wikipedia Vortioxetine
Fluvoxamine
Type Antidepressant
Group SSRI
links
Medscape Fluvoxamine
PubChem 5324346
PubMed Fluvoxamine
Kompas (Dutch) Fluvoxamine
Wikipedia Fluvoxamine

Switch medication from vortioxetine to fluvoxamine.

Nietinrijdenbord.png Stop vortioxetine
Eenrichtingbord.png Start fluvoxamine
Infobord.png More information
The editors of psychiatrienet.nl take the greatest care to provide up-to-date and accurate information on this site. Nevertheless, mistakes and omissions cannot be entirely excluded. No rights devolve from the information provided. The editors and other providers of information to this site accept no responsibility for the content of this site or for the information provided therein; neither do they accept responsibility for possible damages which may derive from the use of the information on this site or from the linked sites. The editorial board accepts no responsibility for the content of the (linked) sites, for access to them, or for the products and services on these sites, nor for the occurrence of errors, viruses, and/or disruptions in service.
Navigation
About